Research Article
Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
Table 1
Patient’s clinical and pathologic characteristics.
| Age in years at diagnosis | Median 60 (range 28–92) | Follow-up period in months | Mean 44.5 (range 1–114) |
| Parameters | | % | 197 patients |
| Histology | | | Serous | 183 | 92.9 | Endometrioid | 1 | 0.5 | Clear cell tumour | 1 | 0.5 | Mixed | 4 | 2.0 | Others | 8 | 4.1 | FIGO | | | I | 5 | 2.5 | II | 11 | 5.6 | III | 135 | 68.5 | IV | 46 | 23.4 | Histological grading | | | I | 8 | 4.1 | II | 49 | 24.9 | III | 140 | 71.0 | Volume of ascites | | | No ascites | 47 | 23.9 | <500 mL | 77 | 39.1 | >500 mL | 73 | 37.0 | Peritoneal carcinomatosis | | | Present | 174 | 88.3 | Residual tumour mass | | | No residual tumour mass | 103 | 52.3 | <0,5 cm | 34 | 17.3 | <1 cm | 30 | 15.2 | 1-2 cm | 6 | 3.0 | >2 cm | 22 | 11.2 | No tumour | 2 | 1.0 | Response to platinum-based chemotherapy | | | Platinum sensitive | 116 | 58.9 | Platinum resistant | 55 | 27.9 | No platinum chemo | 26 | 13.2 |
|
|